💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @Tickeron | 5 |
| @FlashAlert_me | 4 |
| @quantisnow | 3 |
| @MarcJacksonLA | 2 |
| @stock_titan | 2 |
Recent Tweets for CYTK
 |
@wallstreetmover Mizuho Securities Analyst Reiterated Buy Rating on (CYTK) with price target of $45.00 . Is $CYTK on your radar?...… https://t.co/1VkOqHayPn September 16th 2021, 1:09pm |
|
@wallstreetmover Mizuho Securities Analyst Reiterated Buy Rating on (CYTK) with price target of $45.00 . Is $CYTK on your radar?...… https://t.co/Ow251ekbHY September 16th 2021, 1:09pm |
 |
@stockmktgenius $CYTK Cytokinetics, Incorporate Top stock up 120% from low. Close: 33.47 VolvsAvg: 0.51 Liq: $17M https://t.co/zrIYQs9N1j September 15th 2021, 10:09pm |
 |
@Tickeron $CYTK in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/clNPqBP4lf September 15th 2021, 9:09pm |
 |
@tick_signals $CYTK is bullish above 31.38. CYTK EMA 5 Days crossed above EMA 20 Days. Out of 10 EMA5 - EMA20 Crossovers, 6 tim… https://t.co/VaIKjHNFR7 September 15th 2021, 12:09pm |
 |
@jpiipj The annual salary of $CYTK is a concern. I collected and analyzed data on the firm’s performance and industry, and… https://t.co/bEXewnhMBQ September 15th 2021, 7:09am |
 |
@options__edge Added another share of $CYTK yesterday. Got the "sell off" I was looking for. Played this by watching the Histogra… https://t.co/QnearpnmU4 September 15th 2021, 2:09am |
|
@Tickeron $CYTK's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/fIkRWl3baB September 14th 2021, 4:09am |
 |
@42Stocks 2021-SEP-13 6:55pm $CYTK #Cytokinetics up 6.64% = $163.7 million gain. (Sep 13) Cytokinetics, Incorporated (NASDAQ… https://t.co/bB9EqvKiCB September 13th 2021, 10:09pm |
 |
@Sports_bios $CYTK is basically the HCM story, ALS on the side.. and OmeM HF sitting way behind in the dark corner.. haha.. September 13th 2021, 5:09pm |
 |
@IOInvestors Cytokinetics $CYTK Announces Redwood-HCM and Galactic-HF Trial Results Evaluating Omecamtiv Mecarbil in Black Patie… https://t.co/UUaUCbtCt3 September 13th 2021, 4:09pm |
 |
@BigCForever Why TF invest in bios? $cytk on bad data would gone -50% On perceived good data.. up few dimes. ???? September 13th 2021, 3:09pm |
 |
@MC_OptionTrades $CYTK 17-Sep-21 Straddle Implies a ±8.3% move. Sep 14 Morgan Stanley 19th Annual Global Healthcare Conference https://t.co/RAQCvG1R6t September 13th 2021, 2:09pm |
 |
@EdgarInsider New Form 8-K [Press/News Current Report] entry filed by $CYTK CYTOKINETICS INC https://t.co/kVjnwxtcHm September 13th 2021, 11:09am |
 |
@quantisnow $CYTK ? Cytokinetics, Incorporated filed SEC Form 8-K: Other Events https://t.co/HuFCarmdFj 30 seconds delayed. September 13th 2021, 11:09am |
 |
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on September 13, 07:30:24: Item8.01: Other Material Events https://t.co/XtVJFAFQ0j September 13th 2021, 11:09am |
 |
@Briefingcom $CYTK: Cytokinetics reports results from REDWOOD-HCM and GALACTIC-HF presented in late breaking clinical trial... https://t.co/IJ5GyrcdDD September 13th 2021, 11:09am |
 |
@intratio $CYTK https://t.co/ckVs4yMPdN Cytokinetics Inc Our advanced model computed this company s stock price is aligned wi… https://t.co/mCZJMTLDeS September 13th 2021, 1:09am |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in CYTOKINETICS INCORPORATED COM $CYTK https://t.co/we727sKvKi September 12th 2021, 6:09pm |
 |
@OryoJohn $CYTK... defined as resting gradient <30 mmHg and post-Valsalva gradient <50 mmHg at Week 10 compared to placebo (7.7%). September 12th 2021, 5:09pm |
|
@OryoJohn $CYTK treatment with aficamten for 10 weeks resulted in statistically significant reductions from baseline compared… https://t.co/piDeVwYVdm September 12th 2021, 5:09pm |
 |
@MarcJacksonLA $CYTK Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Ses… https://t.co/YOvbiuQhEs September 12th 2021, 5:09pm |
 |
@Biokhan92 RT @OxAnalyst: $CYTK similar to LVOT and LVEF endpoints, ?1 NYHA class improvement seen much earlier than $BMY mava (10 weeks vs. 30 weeks)… September 12th 2021, 5:09pm |
 |
@otcdynamics $CYTK Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Ses… https://t.co/q8uB5u74Cg September 12th 2021, 4:09pm |
 |
@TradingAllIn $CYTK Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Ses… https://t.co/XQqcBzu3Ou September 12th 2021, 4:09pm |
 |
@OxAnalyst $CYTK similar to LVOT and LVEF endpoints, ?1 NYHA class improvement seen much earlier than $BMY mava (10 weeks vs.… https://t.co/WPZ50sxiHs September 12th 2021, 4:09pm |
 |
@phasefivebot $CYTK Cytokinetics Announces Results From Redwood-Hcm And Galactic-Hf Presented In Late Breaking Clinical Trial Ses… https://t.co/QDC4sAc23F September 12th 2021, 4:09pm |
 |
@john_bresnahan $CYTK CYTOKINETICS ANNOUNCES RESULTS FROM REDWOOD-HCM AND GALACTIC-HF PRESENTED IN LATE BREAKING CLINICAL TRIAL SE… https://t.co/BOP0FcECjo September 12th 2021, 4:09pm |
 |
@tigitation Briefly going over on the train, liking the look of $CYTK full Ph2 REDWOOD-HCM results. September 12th 2021, 3:09pm |
 |
@StckPro $CYTK NEW ARTICLE : Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clin… https://t.co/YbF4EELjFV September 12th 2021, 3:09pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on September 12, 11:45:00: Cytokinetics Announces Results From REDWOOD-H… https://t.co/3HPd70pWHU September 12th 2021, 3:09pm |
 |
@StockNewsBot2 $CYTK Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Ses… https://t.co/OnMnBzDG7W September 12th 2021, 3:09pm |
|
@quantisnow $CYTK ? Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial S… https://t.co/KcTrbFqIVZ September 12th 2021, 3:09pm |
 |
@stock_titan $CYTK Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Ses… https://t.co/ndCeb7hYmO September 12th 2021, 3:09pm |
 |
@bthefirsttoknow First out// $CYTK: Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clini… https://t.co/rV72K3NAhh September 12th 2021, 3:09pm |
 |
@MarketChmln $CYTK option volume was 10X normal on Friday with 6,293 contracts. Call volume was 3% and put volume was 97%. https://t.co/DfZwttxsJM September 11th 2021, 9:09pm |
 |
@StockTipRobot The probability of this advice being random is high. Still, pick up some Cytokinetics, $CYTK #NotStonks September 11th 2021, 9:09am |
|
@Tickeron $CYTK's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/SBNXyRrxMQ September 11th 2021, 5:09am |
|
@MC_OptionTrades $CYTK 17-Sep-21 Straddle Implies a ±13.2% move. Sep 13 HFSA Annual Scientific Meeting https://t.co/RAQCvG1R6t September 10th 2021, 7:09pm |
|
@BigCForever Bot $cytk Yes hoping a buyout. September 10th 2021, 3:09pm |
 |
@InsiderForms $CYTK Insider Malik Fady Ibraham has Sold 2,000 Shares. Title :EVP Research; Development Total Cost: $62,860.0 Buy/… https://t.co/hMBy59Meia September 9th 2021, 11:09pm |
 |
@fintel_io Insider Fady Ibraham Malik reports selling 2,000 shares of $CYTK for a total cost of $62,860.00 https://t.co/raHE4aqIEX September 9th 2021, 11:09pm |
|
@QuantchaIdeas Covered Call Alert: CYTOKINETICS INCORPORATED COM $CYTK returning up to 28.16% through 18-Feb-2022 https://t.co/YZmiCfRLQN September 9th 2021, 4:09pm |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator recovers from overbought zone. View odds for this and other indicators:… https://t.co/t1Qx5TVvDa September 9th 2021, 5:09am |
 |
@Cytokinetics $CYTK Investors: Today we announced that we will be participating in three upcoming virtual investor conferences:… https://t.co/h7NEyiwsCh September 8th 2021, 8:09pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on September 08, 16:00:00: Cytokinetics to Participate in September Inve… https://t.co/vLUZWRGid0 September 8th 2021, 8:09pm |
|
@Cytokinetics $CYTK Investors: Today we announced that management will be hosting a conference call and webcast on 9/13 at 8:30 A… https://t.co/BgGqKn53BI September 7th 2021, 11:09pm |
|
@MarcJacksonLA $CYTK Cytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annua… https://t.co/ju8V9m4n03 September 7th 2021, 7:09pm |
|
@otcdynamics $CYTK Cytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annua… https://t.co/mCDL97OGqM September 7th 2021, 12:09pm |
|
@phasefivebot $CYTK Cytokinetics To Host Investor Call And Webcast To Discuss The Full Results From Redwood-Hcm At The Hfsa Annua… https://t.co/ymgrL6IwLI September 7th 2021, 11:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?